Markets◆ Mixed
Lupin launches fixed-dose triple-combination inhaler for COPD in India
· BS Companies
Formoflo-G MDI combines three established therapies in a twice-daily inhaler after DCGI approval, targeting India's large COPD patient…
Continue in the original report ↗